These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3019865)

  • 1. Histologic features associated with long-term survival in breast cancer.
    Dawson PJ; Karrison T; Ferguson DJ
    Hum Pathol; 1986 Oct; 17(10):1015-21. PubMed ID: 3019865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Invasive ductal carcinoma with coexisting ductal carcinoma in situ (IDC/DCIS) versus pure invasive ductal carcinoma (IDC): a comparison of clinicopathological characteristics, molecular subtypes, and clinical outcomes.
    Goh CW; Wu J; Ding S; Lin C; Chen X; Huang O; Chen W; Li Y; Shen K; Zhu L
    J Cancer Res Clin Oncol; 2019 Jul; 145(7):1877-1886. PubMed ID: 31089799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraductal (intracystic) papillary carcinoma of the breast and its variants: a clinicopathological study of 77 cases.
    Lefkowitz M; Lefkowitz W; Wargotz ES
    Hum Pathol; 1994 Aug; 25(8):802-9. PubMed ID: 8056421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Staging in the therapy of cancer of the breast.
    Silverberg SG
    Am J Clin Pathol; 1975 Dec; 64(6):756-63. PubMed ID: 173178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pathological findings of breast cancer in patients surviving 25 years after radical mastectomy.
    Dawson PJ; Ferguson DJ; Karrison T
    Cancer; 1982 Nov; 50(10):2131-8. PubMed ID: 6290024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Grade of ductal carcinoma in situ accompanying infiltrating ductal carcinoma as an independent prognostic factor.
    Kim JY; Han W; Moon HG; Park IA; Ahn SK; Kim J; Lee JW; Kim T; Kim MK; Noh DY
    Clin Breast Cancer; 2013 Oct; 13(5):385-91. PubMed ID: 23870857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors influencing survival in infiltrating lobular carcinoma of the breast.
    Sariego J; Byrd M; Kerstein M; Matsumoto T
    Am Surg; 1993 Jul; 59(7):405-9. PubMed ID: 8391768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histological grading of breast cancer. Interobserver, reproducibility and prognostic significance.
    Theissig F; Kunze KD; Haroske G; Meyer W
    Pathol Res Pract; 1990 Dec; 186(6):732-6. PubMed ID: 1964730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of significance of proportions of intraductal and infiltrating tumor growth in ductal carcinoma of the breast.
    Silverberg SG; Chitale AR
    Cancer; 1973 Oct; 32(4):830-7. PubMed ID: 4356480
    [No Abstract]   [Full Text] [Related]  

  • 10. Encapsulated papillary carcinoma of the breast: an invasive tumor with excellent prognosis.
    Rakha EA; Gandhi N; Climent F; van Deurzen CH; Haider SA; Dunk L; Lee AH; Macmillan D; Ellis IO
    Am J Surg Pathol; 2011 Aug; 35(8):1093-103. PubMed ID: 21753694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histologic variants of infiltrating lobular carcinoma of the breast.
    Fechner RE
    Hum Pathol; 1975 May; 6(3):373-8. PubMed ID: 166034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nucleolar organizer regions: a prognostic factor in infiltrating ductal carcinoma in the breast.
    Canepa M; Gambini C; Borgiani L; Pastorino A; Buccaran G; Gallo L; Storace A; Rovida S
    Pathologica; 1993; 85(1096):151-62. PubMed ID: 8395684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of the clinicopathological characteristics and prognosis in 674 cases of breast intraductal papillary tumor].
    Wang WY; Wang X; Gao JD; Wang J; Liu JQ; Wang X; Zhao DB
    Zhonghua Zhong Liu Za Zhi; 2017 Jun; 39(6):429-433. PubMed ID: 28635232
    [No Abstract]   [Full Text] [Related]  

  • 14. Pathologic correlates of prognosis in lymph node-positive breast carcinomas.
    Clayton F; Hopkins CL
    Cancer; 1993 Mar; 71(5):1780-90. PubMed ID: 8383579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of the in situ component in 389 infiltrating ductal breast carcinomas.
    Carabias-Meseguer P; Zapardiel I; Cusidó-Gimferrer M; Godoy-Tundidor S; Tresserra-Casas F; Rodriguez-García I; Fábregas-Xauradó R; Xercavins-Montosa J
    Breast Cancer; 2013 Jul; 20(3):213-7. PubMed ID: 22271067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vimentin expression appears to be associated with poor prognosis in node-negative ductal NOS breast carcinomas.
    Domagala W; Lasota J; Dukowicz A; Markiewski M; Striker G; Weber K; Osborn M
    Am J Pathol; 1990 Dec; 137(6):1299-304. PubMed ID: 1701960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathological prognostic factors in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma: a study of 644 patients with median follow-up of 18 years.
    Rosen PP; Groshen S; Saigo PE; Kinne DW; Hellman S
    J Clin Oncol; 1989 Sep; 7(9):1239-51. PubMed ID: 2549203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tubular carcinoma of the breast. A long term follow-up.
    Carstens PH; Greenberg RA; Francis D; Lyon H
    Histopathology; 1985 Mar; 9(3):271-80. PubMed ID: 2987100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biologic behavior and long-term outcomes of breast ductal carcinoma in situ with microinvasion.
    Fang Y; Wu J; Wang W; Fei X; Zong Y; Chen X; Huang O; He J; Chen W; Li Y; Shen K; Zhu L
    Oncotarget; 2016 Sep; 7(39):64182-64190. PubMed ID: 27577080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphology of male breast carcinoma in the evaluation of prognosis.
    Cunha F; André S; Soares J
    Pathol Res Pract; 1990 Dec; 186(6):745-50. PubMed ID: 1964731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.